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Abstract: Pseudomonas aeruginosa is considered a public threat, with antibiotics increasing their re-
sistance. Essential oils (EOs) have demonstrated significant effects against microorganisms. How-
ever, due to their volatile nature, they cannot be used in their free-state. Here, hydrogel-like films 
were produced from a combination of sodium alginate (SA) and gelatin (GN) to serve as delivery 
platforms for the controlled release of cinnamon leaf oil (CLO) entrapped within chitosan (CS) mi-
crocapsules. The minimum inhibitory concentration (MIC) of CLO was established at 39.3 mg/mL 
against P. aeruginosa. CS microcapsules were prepared via ionotropic gelation with tripolyphos-
phate (TPP), encapsulating CLO at MIC. Successful production was confirmed by fluorescent mi-
croscopy using Nile red as a detection agent. Microcapsules were embedded within a biodegradable 
SA/GN polymeric matrix processed by solvent casting/phase inversion with SA/GN used at 70/30 
polymer ratio at 2 wt.% SA concentration. A concentration of 2 wt.% CaCl2 was used as a coagulation 
bath. The CLO-containing CS microcapsules’ homogeneous distribution was guaranteed by succes-
sive vortex and blending processes applied prior to casting. CLO controlled release from the films 
was monitored in physiological pH for 24 h. Hydrated films were obtained, with the presence of 
loaded CS capsules being confirmed by FTIR. Qualitative/quantitative antimicrobial examinations 
validated the loaded film potential to fight P. aeruginosa. 




Pseudomonas aeruginosa, a Gram-negative and monoflagellated bacteria is considered 
a microorganism of great clinical relevance. It is a very powerful opportunistic human 
pathogen that survives under a great variety of conditions, causing infections, not only in 
immunocompromised cancer patients but also in patients suffering from burns and cystic 
fibrosis [1]. P. aeruginosa-derived infections are difficult to eradicate due to this bacterium 
elevated intrinsic antibiotic resistance. As a result, this microorganism is categorized as a 
human pathogen with high antibiotic resistance by the Infectious Diseases Society of 
America [2,3]. 
Several antimicrobial agents, including antibiotics, have been used to fight P. aeru-
ginosa-related infections. Yet, their excessive consumption and misuse has led to an in-
creased appearance of antibiotic resistance [4], hence the current urgency in finding alter-
natives. In recent years, plant-derived products, possessing promising features, such as 
antimicrobial, anti-inflammatory and antioxidant effects, have gained a new importance 
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as antibiotic replacements by effectively treating infections and causing little impact in the 
human health [5]. Essential oils (EOs) consist of blends of volatile biomolecules, obtained 
from different areas of the plants, that defend the host immune system from microorgan-
isms [6]. Many studies have proven their ability to work as alternatives to antibiotics, since 
they present strong anti-inflammatory and antiseptic properties, for instance [7]. How-
ever, their cytotoxicity at elevated concentrations and their high volatility still constitute 
challenges to overcome prior to their generalized consumption [8]. 
Polymeric nanocapsules that contain a liquid core encapsulated within a polymer-
based shell, have been highlighted as effective drug carriers [9]. By encapsulating antimi-
crobial agents at the core, these polymeric systems can increase the drug-loading effec-
tiveness, decrease the nanoparticles content and isolate the loaded material from the sur-
rounding environment. Moreover, this isolation prevents secondary undesirable effects 
related with early degradation and burst release, which can be induced by external factors, 
like alterations in pH and temperature, or presence of enzymes [10,11]. The properties of 
the shell material strongly influence the nanocapsule constancy in a physiological envi-
ronment, its entrapment effectiveness and loaded molecules release profile. Polysaccha-
rides have been commonly used as transporters of biomolecules, due to their biodegrada-
bility rate, compatibility with human cells, gelation capacity and mucoadhesiveness. Fur-
thermore, they possess deprotonated amino or carboxylic acid groups, which will turn the 
surfaces cationic or anionic, enabling the formation of shells by electrostatic interactions 
[12]. Chitosan is a natural copolymer, obtained by deacetylation of chitin, that has the 
ability to form nanocapsules with a positive surface charge. The cationic surface is respon-
sible for improving the interactions between the nanoparticles and some Gram-negative 
bacteria, through electrostatic interactions, thus increasing its ability to fight infections 
[13,14]. 
In this study, an optimized delivery platform was engineered for a targeted and con-
trolled release of cinnamon leaf oil (CLO), a very powerful antimicrobial EO, entrapped 
within chitosan microcapsules, using hydrogel-like films produced from a combination of 
sodium alginate (SA) and gelatin (GN). This is the first report on the CLO controlled re-
lease from chitosan microcapsules embedded within a SA/GN matrix for the eradication 
of P. aeruginosa bacteria. 
Hydrogel-films are widely used for cell microencapsulation since they present a high 
porosity that results in a high permeability of oxygen, nutrients and metabolites. SA and 
GN are both very frequently used in biomedicine, due to their biocompatibility and bio-
degradability [15]. SA is a water-soluble salt and a natural, biocompatible polysaccharide 
found in brown algae [1,2] endowed with great biocompatibility, low immunogenicity 
and minor gelation conditions [14]. SA is often used in cell encapsulation since it presents 
a fast ionic gelation with divalent cations [15]. However, alginate alone is unable to pro-
vide a good cell attachment, which will result in low interactions between the cells and 
the material. In addition, this polymer displays a random degradation profile [16]. There-
fore, in order to overcome these limitations, GN is frequently applied [17,18]. GN is a pro-
tein, formed by collagen hydrolysis, and has been used for controlled drug release due to 
its biodegradability and biocompatibility [19]. 
2. Experiments 
2.1. Materials 
Pure cinnamon leaf oil (CLO, extracted from Cinnamomum zeylanicum, ρ = 1.049) was 
obtained from Folha d’Água Company (Santo Tirso, Portugal). Nutrient broth (NB) and 
nutrient agar (NA) were purchased from VWR, while Mueller–Hinton broth (MHB) was 
acquired from CondaLab. P. aeruginosa (ATCC 25853) was obtained from the American 
Type Culture Collection (ATCC). 
Chitosan (CS, Mw 100–300 kDa, Acros Organics, Fair Lawn, NJ, USA) and sodium 
tripolyphosphate (TPP, Sigma, St. Louis, MO, USA) were used in the production of the 
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microcapsules. Gelatin (GN, ~300 Bloom, Type A from porcine skin) and sodium alginate 
(alginic acid sodium salt, SA, from brown algae, ≥2000 cP) were acquired from Sigma and 
used to produce hydrogel-like films. Distilled water (dH2O) was used as the polymer’s 
solvents, and a 2-wt.% solution of calcium chloride (CaCl2 anhydrous, Chem-Lab) was 
employed as a coagulation bath. 
2.2. Scanning Electron Microscopy (SEM) Observations 
Visual studies using SEM were carried out to evaluate the potential of CLO to affect 
the morphology of the P. aeruginosa bacteria. Bacteria suspensions were prepared with a 
concentration of 1 × 107 CFUs/mL in MHB, and combined with CLO at minimum inhibi-
tory concentration (MIC) (39.3 mg/mL), at a 50/50% (v/v) [20]. Afterwards, 500 µL of the 
solution (composed of CLO and bacteria) were put into contact with 12-well tissue culture 
plates (TCPS) and left at 37 °C for 24 h, with stirring at 120 rpm. The control consisted of 
bacteria free from the influence of the oil. Then, the media was eliminated, and surfaces 
were treated with 500 µL of 2.5 % (v/v) of glutaraldehyde in PBS for 1 h at room temper-
ature (RT), to fix the cells in their current form. Finally, the plates were washed with dH2O 
and using ethanol dilutions (55, 70, 80, 90, 95, 100 % (v/v), 30 min each at RT) the cells 
were subsequently dehydrated. In the end, the residual ethanol was evaporated at RT. 
Samples were collected from the TCPS plates using a hot press-on device and covered 
with a 10-mm thickness film of Au–Pd (80–20 wt.%) in a 208-resolution sputter coater 
(Cressington Company, Watford, UK), with an MTM-20 Cressington high resolution 
thickness controller. Lastly, bacteria were observed via FEG-SEM (NOVA 200 Nano SEM, 
FEI Company, Montreal, QC, Canada), with an electron accelerating voltage of 10 kV. 
2.3. CLO Encapsulation: Chitosan Microcapsules Production 
Prior to any processing, CS was desiccated at 50 °C for 24 h to eliminate any water 
trace. For microcapsule production, four processing conditions were selected (Table 1). In 
all cases, firstly, CS was hydrated in dH2O for 30 min, and then acetic acid was added 
dropwise (under strong stirring), and left blending for 2 h. TPP was prepared in dH2O 
under slow stirring for 1 h. In case of the CS4 and CS4N solutions, the pH of both CS and 
TPP was set to 5.0. 
CLO was added dropwise to the CS1 and CS4 and left to blend for 10 min. In the 
CS1N and CS4N (Nile Red-containing samples), CLO corresponding volumes were also 
added, and 2 min after its addition, a solution containing Nile Red was added and left 
under stirring for 8 min. Then, TPP was combined dropwise with all solutions under 
strong stirring. The solutions were homogenized in an Ultraturrax (T25 digital, IKA®) on 
a pulsation mode (10 s ON, 10 s OFF) repeated 5 times, and then transferred to dialysis 
membranes (SnakeSkin 10 kDa cut-off, Thermo Fisher, Waltham, MA, USA). The dialysis 
was performed in dH2O and the water was exchanged 3 times over a period of 24 h. 
Table 1. Chitosan (CS) microcapsules processing conditions (* after pH adjustment). 
Sample CS (mg) dH2O (mL) Acetic Acid (µL) CLO (µL) Nile Red (µL) TPP (mL) pH Adjust NaOH (mL) dH2O * (mL) 
CS1 2.5 9.9 100 834 - 9 No - - 
CS1N 2.5 9.9 100 834 166 9 No - - 
CS4 2.5 6.9 100 834 - 9 Yes 1.1 1.9 
CS4N 2.5 6.9 100 834 166 9 Yes 1.1 1.9 
2.4. SA/GN Films Production 
SA/GN films were produced by mixing the SA and GN solutions in a ratio of 70:30 
v/v. SA (2% w/v) and GN (~1% w/v) were dissolved separately in dH2O at 50 °C under 
stirring for 3 h and 1 h, respectively. GN was added to the SA solution and blended under 
slow stirring until a homogeneous solution was obtained (~1 h). The solutions were then 
poured into glass petri dishes of 140 mm diameter (40 mL), left at 4 °C overnight to remove 
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air bubbles, and subsequently slowly dried at RT for 6 days. A 2 wt.% CaCl2 solution was 
then added to the petri dishes containing the films for crosslinking. After 1 h of contact, 
the films were detached from the dishes and washed in 100 mL of dH2O at 150 rpm for 5 
min, a process that was repeated 3 times. To prepare the SA/GN films containing CLO 
microcapsules, the solutions CS1 and CS4, after being subjected to dialysis, were added to 
the SA/GN solutions and kept under low stirring for 30 min; their water content was used 
as complementing solvent for the polymers. The following steps were kept equal to the 
unloaded films. 
2.5. Chemical Characterization: ATR-FTIR 
Attenuated total reflectance-Fourier transform infrared spectroscopy (ATR-FTIR) 
was used to analyze the surface and structural chemistry of the films. The wavenumber 
ranged between 400 and 4000 cm−1 using an IRAffinity-1S (Shimadzu, Japan), coupled 
with a diamond crystal. A total of 200 scans were conducted per film type at a 2-cm−1 
spectral resolution. 
2.6. CLO Release Profile from the Loaded Films 
Unloaded and loaded films were left at 37 °C and 120 rpm in simulated body fluid 
(SBF) prepared at physiological pH (7.4). The release of CLO was monitored after 1, 2, 6 
and 24 h of incubation. A spectophotometer UV-VIS (UV-1800, Shimadzu, Kyoto, Japan) 
was used to analyze the CLO presence within the SBF (release) overtime at the wavelength 
of 280 nm (characteristic of CLO) [21]. 
2.7. Time–Kill Kinetics 
P. aeruginosa was blended with NB at 1 × 105 CFUs/mL, and then combined with CLO 
or CLO-loaded films at MIC. Free bacteria and unmodified SA/GN films were used as the 
control. Testing cultures were incubated at 37 °C and 120 rpm, and after 1, 2, 6 and 24 h, 
aliquots were collected and diluted in PBS (101 to 105) for further culturing in NA plates 
for 24 h at 37 °C. Live colonies were identified and counted, and the resulting amount 
expressed in mean ± standard deviation (S.D.). Log reduction studies were performed be-
tween unloaded and loaded films and reported as the mean ± S.D (n = 3, GraphPad Prism 
7.0 software). 
3. Results and Discussion 
3.1. Cell Wall Disruption 
The CLO interference with the Gram-negative bacteria cell membrane was examined 
via SEM after 24 h of contact with CLO at MIC. Figure 1 shows the resulting morphology 
of the bacteria. Prior to any contact with the antimicrobial agent, P. aeruginosa bacteria 
exhibited a rod-like shape structure with a very smooth and uninterrupted surface. P. ae-
ruginosa cells may also present polar flagella that confer the cells with mobility [20,22]. 
Here, however, those were not detected. Still, many cells revealed signs of undergoing 
polar binary fission. 
CLO acts against the cytoplasmic membrane of bacteria by accumulating at the cell 
surface and disrupting its functions and integrity, increasing the odds of cell content leak-
age and ultimately cell death [23]. Here, it was evident that CLO increased the P. aeru-
ginosa bacteria permeability, deforming its original morphology with the appearance of 
holes or wrinkles along the membrane. CLO surrounded the cells, isolating them for an 
effective permeabilization. Since these bacteria are relatively more resistant to hydropho-
bic biomolecules than Gram-positive bacteria to overcome their impermeability, CLO re-
lied on the isolation of cells, in order to traverse the outer cell layer and reach the intracel-
lular space [20,24]. 





Figure 1. Micrographs of the P. aeruginosa morphology: (a) before and (b) after contact with cinna-
mon leaf oil (CLO). 
3.2. Microcapsules Observation 
Fluorescence Microscopy (DM IL LED, Leica Mycrosystems, Wetzlar, Germany) with 
40× magnification was applied to observe the microcapsules. Figure 2 represents the mor-
phology of CS1 and CS4 samples before and after dialysis, prior to their incorporation 
onto films and to any contact with P. aeruginosa. For both samples (CS1 and CS4) it was 
evident that the non-reacted polymer was eradicated after dialysis (Figure 2b,d). Further-
more, it is visible that the sample CS4 contains larger microcapsules and more unloaded 
chitosan aggregation (Figure 2c,d) than CS1. Therefore, it was concluded that the produc-
tion of the samples without pH adjustment (CS1) was more effective. 
    
(a) (b) (c) (d) 
Figure 2. CS1 and CS4 morphology (a,c) before and (b,d) after dialysis, respectively. 
3.3. Chemical Characterization 
ATR-FTIR spectra of the SA/GN films unloaded with loaded with CS1 and CS4 were 
collected (Figure 3). A slightly broad band centered at ≈3420 cm−1 was observed in all spec-
tra and it was attributed to the hydrogen bonded O–H stretching vibrations. It was ex-
plained by the polymers’ affinity to water molecules. Characteristic peaks of each individ-
ual polymer were detected at 1416 and 1036 cm−1 for SA, ascribed to the symmetric stretch-
ing vibration of the carboxylate group and the C-O stretching vibrations [15], respectively, 
and at 1225 and 1063 cm−1 for GN, which revealed the presence of amide III (stretching 
bonds of C-H and bending bonds of N-H) and C-O stretching vibrations [17,18], respec-
tively. Presence of CLO was detected by the appearance of a peak at 1724 cm−1, appointed 
to the C=O stretching vibrations of the oil components, and the presence of a very smooth 
peak at 1543 cm−1, which is attributed to the aromatic ring C=C skeleton vibration [4]. CLO 
was more easily noticeable on the CS4-containing films than on the CS1, which may indi-
cate that the EO molecules were larger. 




Figure 3. Attenuated total reflectance (ATR)-FTIR spectra of the sodium alginate (SA)/gelatin (GN) 
unloaded and loaded with CS1 and CS4. 
3.4. CLO Release Profile 
The CLO release profile from the CS1 and CS4 loaded films in the presence of SBF 
was assessed for a period of 24 h (Figure 4). The influence of SA and GN was considered 
and eliminated from the obtained profile. SA/GN/CS1 released the CLO gradually, in a 
constant-like manner, with the strongest burst release being detected at the 2-h period and 
reaching an equilibrium within the 24-h period. On the other hand, the SA/GN/CS4 sam-
ples, were only able to start releasing the CLO after 2 h. For the entire test, their release 
profile was always inferior to that of the CS1-containing films. This occurred because 
when the CS and TPP pH’s were adjusted to 5, a stronger interface was achieved between 
the capsules and the films, thus narrowing CLO’s release. Moreover, at this pH the higher 
presence of clusters (as observed in Figure 2) may have reflected in a greater oil retention 
under the tested conditions. 
 
Figure 4. CLO release profile from 1 h to 24 h of incubation in simulated body fluid (SBF). 
3.5. Time–Kill Kinetics 
The time–kill curves of the loaded films were assessed by the number of live cells 
after 1, 2, 6 and 24 h (Figure 5). The relative log reduction between the unloaded and 
loaded films was also verified. In the first hour of interaction, all films promoted the bac-
teria growth. However, as the release of the CLO from the films intensified (Figure 4), so 
did its action against the bacterium. Indeed, at the 2-h target the SA/GN/CS1 experienced 
a significant reduction in the number of viable bacteria. Furthermore, its log reduction 
became significantly enhanced in comparison to the CS4-loaded films. From 6 h to 24 h 
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the reduction in viable cells continued. The main component of CLO, the eugenol, is 
known to interfere with the intracellular roles or ion transport of the cells, causing diffi-
culty for metabolites and connection pathways from taking place and resulting in cell 
death [4]. Still, due to the reduced release of the CS4 from the films after 6 h, the action 
against the bacterium became compromised on the CS4-containing films, allowing viable 
cells to continue multiplying and increasing their number in the media. Once again, the 
presence of agglomerates that surrounded the CLO-loaded microcapsules may have pre-
vented their release and consequent effective action. 
 
Figure 5. Time–kill kinetics of the P. aeruginosa bacteria in contact with the unloaded and loaded films and log reduction 
in the loaded films in relation to the control (unloaded SA/GN). 
4. Conclusions 
At the end of this research, it was confirmed the incorporation of the CLO-containing 
CS microcapsules within the SA/GN fibers. The continuous release of the entrapped oil 
over a period of 24 h was attained, with matched time–kill kinetics against the P. aeruginosa 
bacteria. CS1 loaded films were determined more effective than the CS4-loaded or the 
unloaded surfaces. Future work will be aimed at improving the loading capacity and ho-
mogeneity of the microcapsules, so a more effective antimicrobial profile and prolonged 
release can be achieved. 
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